COCHRANE HONG KONG The 2nd Cochrane Hong Kong Symposium, held on 26 March 2026, the first day of the 8th Pan-Pacific Nursing Conference, brought together leading experts from the Cochrane global network to explore how trusted, high-quality evidence can transform healthcare policy, practice, and patient outcomes. Supported by Cochrane Hong Kong Co-Directors Prof. Wai Tong CHIEN and Prof. Janita CHAU, along with Cochrane Hong Kong Management Committee members Prof. Sek Ying CHAIR, Prof. Kai Chow CHOI and Prof. Winnie SO (moderator), the symposium featured a three-part programme: 1. From Global to National Perspectives Mr. Toby LASSERSON (Cochrane Library) opened with a keynote on Cochrane’s strategic priorities for sustaining high-impact evidence synthesis worldwide. Prof. Ling LI (Sichuan University) followed with an overview of Cochrane China Network’s development over the past five years and its expanding role in advancing evidence-based healthcare across the nation. 2. Evidence for Quality Improvement Prof. Yaolong CHEN (Lanzhou University) discussed how clinical practice guidelines serve as a vital link between research and quality improvement. Prof. Qin LIU (Chongqing Medical University) highlighted youth mental health, calling for stronger evidence integration to bridge care gaps. 3. Implementation Challenges Ms. Ana Beatriz PIZARRO (Cochrane Central Executive Team) concluded the symposium by examining barriers and knowledge translation challenges in Latin America, emphasising the importance of sustained international collaboration for effective evidence implementation. | 
